INBX

Inhibrx BiosciencesD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

INBX vs peer average

29/100

INBX vs. peer average (D vs. C)

Grade spread

A 2 · B 3 · C 1 · D 2 · F 1

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

ACRS is the first available peer comparator.

Small‑cap clinical biotech with binary trial risk and funding sensitivity—behavioral peer for volatility expectations.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerACRSAclaris Therapeutics

INBX

Inhibrx Biosciences

ACRS

Aclaris Therapeutics

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Defensive

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs ACRS

INBX / ACRS

Grade Position

Below peers

INBX vs. peer average (D vs. C)

29/100

Momentum

ACRS

Value

INBX

Sentiment

ACRS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs INBX

ACRS

100/100

-3

ALNY

80/100

-2

BNTX

40/100

Even

MBX

MBX Biosciences Inc Common

N/A

PURR

Hyperliquid Strategies Inc Common

N/A

ACRS is the first peer returned for this comparison set.